![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Arnold Suhr Qimpex Pte. Ltd. Singapore Sg, based in Singapore, is a pharmaceutical company.
One of their significant offerings is Quinine sulfate, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2003-168 - Rev 01
This Chemical Type CEP, issued on October 25, 2010, remains in force until March 09, 2016, ensuring its reliability within the pharmaceutical industry.
Substance Number 19 associated with this CEP further emphasizes